Metformin HCl
| Product | Metformin HCl |
| Pharmaceutical Form | Ready to compress granules |
| Strengths | 78.12% |
| Release Charecteristics | Sustained Release (like Bristol-Myers Squibb – Glucophage XR 500 mg & 750 mg Tablets) |
| Indications | Management of type 2 diabetes |
| Posology | Once daily |
| Raw Material | DMF available |
| Technical Documents | Available in CTD format |
| Registration underway | Iran |
| Marketing | Nepal |
Description
Ready to compress granules